Managed Care

 

Patients, HMO win with cheaper drug

MANAGED CARE September 2009. © MediMedia USA
The Formulary Files

Patients, HMO win with cheaper drug

MANAGED CARE September 2009. ©MediMedia USA













It’s pretty common. A health plan decides to change its formulary, looking for ways to decrease costs. But formulary selections affect the provider’s choice of medication and the patient’s satisfaction with therapy. Researchers at Wilkes University in Wilkes Barre, Pa., looked at surrogate outcomes when a potent statin, atorvastatin (Lipitor), was removed from the formulary of a Medicaid HMO. Surrogate outcomes are laboratory results or vital signs.

“We were alarmed by how this change might affect patient lipid panels,” says Daniel S. Longyhore, PharmD, of the department of pharmacy practice at Wilkes University and lead investigator.

The researchers expected poorer outcomes. They also thought poorer outcomes could help make the case to the HMO to reconsider its formulary choices.

“That didn’t happen,” says Longyhore. “Patients were just as well controlled by drugs that were not as potent as atorvastatin and that were available in generic form. This was a significant cost savings to the patient and the plan, plus a blessing to find these good surrogate outcomes.”

For payers, “It’s a sign that sometimes it’s better to stick to the medication that has been around for awhile, that has proven itself, that is less expensive, and that is just as good as newer drugs,” says Longyhore.

Removing a high-potency statin from the formulary did not change lipid panels significantly

Source: Longhyore DS, Stockton CM, Thomas MR. Lipid profile changes associated with changing available formulary statins: Removing higher potency agents. 2009. Am J Manag Care. 15:409–414.

Meetings

Private Health Insurance Exchanges Conference Washington, D.C. October 7–8, 2014
National Healthcare Facility Management Summit Palm Beach, FL October 16–17, 2014
National Healthcare CFO Summit Las Vegas, NV October 19–21, 2014
National Healthcare CXO Summit Las Vegas, NV October 19–21, 2014
Innovative Member Engagement Operations For Health Plans Las Vegas, NV October 20–21, 2014
4th Partnering With ACOs Summit Los Angeles, CA October 27–28, 2014
2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014